glp-1 in obesity The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer | Cancer and Metastasis Reviews The GLP-1 Access Gap: Mapping
Description
[DOI] [PubMed] [Google Scholar] 25.El-Osta A, Rowe C, Majeed A
Epidemiology of diabetes
As both incretin hormones are known to modulate glucagon secretion (in opposite ways and at different glucose levels), pharmacological dual incretin receptor agonism may have effects on glucagon secretion that are of clinical importance
No injection sites
